Top

Published in:

01-01-2005 | Clinical Study

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

Authors: Christos Christodoulou, Dimitrios Bafaloukos, Helen Linardou, Gerassimos Aravantinos, Aristotelis Bamias, Maria Carina, George Klouvas, Dimosthenis Skarlos

Published in: Journal of Neuro-Oncology | Issue 1/2005

Title: Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
Authors: Christos Christodoulou
Dimitrios Bafaloukos
Helen Linardou
Gerassimos Aravantinos
Aristotelis Bamias
Maria Carina
George Klouvas
Dimosthenis Skarlos
Publication date: 01-01-2005
Publisher: Kluwer Academic Publishers
Published in: Journal of Neuro-Oncology / Issue 1/2005
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-004-9176-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2005

Central Neurocytoma

Brain metastasis in pediatric extracranial solid tumors: survey and literature review

Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature

Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases

Effects of toxic doses of glutamate on Cu–Zn and Mn/superoxide dismutases activities in human glioma cell lines

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases